Actively Recruiting
Effect of Myofascial Release Technique on Central Sensitization, Trigger Points, and Menstrual Symptoms in Women With Primary Dysmenorrhea: Sham-Controlled, Randomized Double-Blind Study
Led by Gazi University · Updated on 2024-11-21
36
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying women aged 18 to 40 with primary dysmenorrhea, a condition causing painful menstrual cramps. The study aims to evaluate how the myofascial release technique affects central sensitization, myofascial trigger points, and menstrual symptoms. This manual therapy method applies gentle, prolonged pressure to muscle and connective tissue to improve pain and function. The goal is to understand its impact on pain sensitivity and menstrual discomfort in affected women. Participants will be randomly assigned to one of two groups: one receiving the active myofascial release technique and the other receiving a sham treatment with light touch but no pressure. The active treatment involves applying the technique to seven specific body regions for about 35 minutes per session, over 10 sessions during a menstrual cycle. The sham group will have the same hand placements and duration, but without therapeutic pressure or tissue release. During the study, researchers will assess participants' pain pressure thresholds, central sensitization levels, and menstrual pain intensity before and after treatment. Secondary measures include menstrual attitudes, quality of life, anxiety, and body awareness. Evaluations will occur on the most painful days and continue through an average follow-up of three months. The trial uses a double-blind design to keep both patients and evaluators unaware of group assignments, ensuring unbiased results.
CONDITIONS
Brief Title
Myofascial Release Technique in Women With Primary Dysmenorrhea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide
- Having regular menstruation in the last 6 months (28�B17 days)
- Experiencing menstrual pain between 40 mm and 100 mm on the Visual Analogue Scale (VAS) in the last 6 months
- Female aged between 18 and 35 years
You will not qualify if you...
- Diagnosed with Secondary Dysmenorrhea
- Having given birth
- Having serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes
- Undergoing urogynecological surgery
- Pregnant or suspected of being pregnant
- Using analgesics or non-pharmacological agents other than NSAIDs for menstrual pain
- Using intrauterine or oral contraceptives
- Taking extra supplements such as magnesium that may affect treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - One menstrual cycle
Participants receive either the myofascial release technique or a sham version over 10 sessions during one menstrual cycle.
10 visits (in-person)
Duration - Approximately 3 months
Participants undergo evaluations of pain, central sensitization, and menstrual symptoms after the treatment period over approximately 3 months.
Follow-up assessments after treatment completion
Trial Site Locations
Total: 1 location
1
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Gazi University
Ankara, Turkey (Türkiye), 06530
Actively Recruiting
Research Team
R
Research Asisstant
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here